Xtx Topco LTD Eye Point Pharmaceuticals, Inc. Transaction History
Xtx Topco LTD
- $2.23 Billion
- Q2 2025
A detailed history of Xtx Topco LTD transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 137,950 shares of EYPT stock, worth $1.88 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
137,950
Previous 43,740
215.39%
Holding current value
$1.88 Million
Previous $237,000
447.68%
% of portfolio
0.06%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding EYPT
# of Institutions
159Shares Held
67.1MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$114 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$92.9 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$92.8 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$62.8 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$58.7 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $465M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...